The Skin and Lupus
By A. G. Moore 5/23/2013

V-sign Rash: Photosensitive Reaction
Photo by:Elizabeth M. Dugan, Adam M. Huber, Frederick W. Miller, Lisa G. Rider
Public Domain on Wikimedia Commons
The skin is the largest organ, so
it's not surprising that the skin is one place where lupus symptoms
often appear. According to the Lupus Foundation, two thirds of
people who have lupus will have some type of skin involvement.
The Lupus Center at Johns Hopkins Hospital in Baltimore likewise
describes the frequent incidence of skin problems in lupus patients.
Dr. Simon Meggitt, of the Royal Victory Infirmary in the UK, recommends that lupus patients with skin issues receive early and effective treatment. There is a tendency, the doctor believes, to dismiss skin issues. However, this attitude underestimates "the far-reaching impact that a skin problem can have...".
While both the Lupus Foundation and Johns Hopkins suggest a dermatologist might be beat qualified to deal with this manifestation of lupus, Dr. Meggitt is more of the mind that one physician--a rheumatologist--oversee the care and the if necessary a dermatologist be on hand for consultation.
Just about everyone agrees that disruption in the skin in people with systemic disease may be a sign that lupus is acting up. That has been my experience; most of my skin issues have been with hives an rashes. Sometimes, when these appear to be of the type that I am used to, I wait to see if they'll clear up on their own or with the application of a very mild topical steroid. However, I never dismiss a rash as unimportant; I take it as a sign that trouble may be brewing. I pay attention to my body and my environment and try to figure out what might have caused the rash. Because whatever made the rash appear could bring on a more generalized flare.
Some of the ways in which lupus can affect the skin are:
Discoid lupus (chronic cutaneous lupus): This form of lupus needs accurate diagnosis and prompt, effective treatment. Usually a doctor can diagnose discoid lupus without a biopsy; sometimes a doctor will call for a biopsy in order to be certain that what appears to be discoid lupus isn't in fact something else
With discoid lupus, the best treatment begins with prevention. Stay away from UV, whether the source be natural (the sun) or artificial (ex., fluorescent lights). After this preventative measure is taken, the first medicines prescribe are generally topical steroids and anti-malarials. If these interventions don't work, doctors may move on to other, more powerful drugs. Sometimes discoid lupus and systemic lupus occur together (about 20% of people who have systemic lupus also have discoid lupus). In about 5% of people who have discoid lupus but not systemic disease, systemic symptoms may later appear.
Cutaneous vasculitis: this symptom occurs when blood vessels under the skin become inflamed. Lesions that develop can be serious. Cutaneous vasculitis requires the attention of a physician and careful monitoring.
Raynaud's phenomenon: this symptom occurs when blood vessels under the skin constrict. What is usually noticed as a change in the color of some extremity (like a hand, nose or ear). Raynaud's used to be one of the diagnostic criteria for systemic lupus, but since this phenomenon is so widespread in the general population, the ACR no longer includes this in its list of eleven lupus symptoms.
Alopecia: not only may hair loss occur as a result of having discoid lesions, but there is often a general thinning of the hair in people who have systemic lupus. "Lupus hair", as the characteristic appearance is sometimes called, looks thin and kind of ragged. Doctors who treat lupus may readily recognize this in a patient with active disease.
Ulcerations in the nose and mouth: these are quite common in lupus. As with other skin disruptions, these may signal that lupus is active.
There are other dermatological manifestations of lupus. The skin is not only our largest organ it is also our most conspicuous. It can tell us a lot about what is going on elsewhere in the body. It's probably a good idea to pay attention to the message it is conveying.
ANAs in the Lupus Puzzle
By A. G. Moore 5/14/2013
Immunofluorescence Pattern of Double Stranded DNA Antibodies
By Simon Caulton
On Wikimedia Commons
"What's going on?"
I asked my doctor. It was 1992. The acute phase of a viral infection had subsided but several symptoms persisted. Joints in my hand were
swollen; my blood pressure was elevated; my thighs and my feet ached.
The doctor examined me, asked questions
and drew blood. He had likely formed an idea about what might be
"going on"; the blood test would give him more clues.
When the lab report came back, he learned something about the
direction his inquiry should take: I had tested positive for
antinuclear antibodies (ANAs). This result was a sign, not an answer.
In order to get an answer, he told me, I needed to see a rheumatologist.
Back then, in 1992, I didn't know what a positive ANA lab report meant. Over time, though, I learned a great deal about this laboratory test. For one thing, I discovered that the term antinuclear antibodies embraces a lot of different kinds of autoantibodies. Autoantibodies are at the heart of autoimmune disease.They are like rogue cells and attack the very organism that has given rise to them.
After a laboratory
sends back a positive ANA finding, the doctor has a range of options:
if the patient is asymptomatic (has no other signs of disease), the
doctor is likely to file the lab report away and do nothing because positive ANA tests are found in about 5% of apparently
healthy people.
Another option a doctor has, if the patient is symptomatic, is to draw blood and send the sample back to the lab for more definitive testing. In my case, the rheumatologist to whom I'd been referred looked for specific antinuclear antibodies. Lupus, at this point, was a distinct possibility. If my second set of lab tests came back positive for particular antibodies, such as anti-double stranded DNA or anti-Smith, then the doctor would have a clearer idea about what he was dealing with. These two antinuclear antiboidies are rarely found in a patient who does not have lupus.
Since that first day--more than 20 years ago--when a doctor told me my blood had tested positive for antinuclear antibodies, I've learned:
* While a positive ANA may indicate an autoimmune disease is present, a negative doesn't eliminate the possibility. Research shows
that about 3% of the people who have lupus are "sero-negative"--that
is, they get a negative ANA lab
result. In
a way, this is unfortunate, because it is so widely believed that ANA
is a threshold test for lupus that precious time may be lost as
doctors look elsewhere for an answer to a patient's complaints. Or,
worse yet, doctors may stop looking for an answer altogether.
* As lab results come in and a patient tests positive for
specific kinds of antinuclear antibodies, doctors may discover exactly what's going
on. Certain antinuclear antibodies are associated with
specific symptoms: anti double stranded DNA, for example, appears often in
lupus patients who have kidney involvement . Anti-Ro is found,
often, in patients with cutaneous lupus (SCLE).
Anti-Ro is also often present in the blood of patients who have both Sogren's Syndrome and systemic lupus.
* ANAs are found not only in autoimmune diseases but also in certain
cancers. Pelvic and breast cancers, for example, may trigger a
positive ANA.
And, it seems that ANAs are found in blood samples at increasing
rates as people grow older--this finding is not associated with
any evident disease process. In one study, 79% of people over the age of 100 had elevated levels of at least one kind of autoantibody.
The most interesting thing I learned about antinuclear antibodies is that, while they can be extremely helpful diagnostically, they are in many ways a mystery. Some researchers question whether they are merely bystanders in the disease process or whether they are themselves precipitators of disease. An article in the Journal of Rheumatology asks just that question. It looks at the role of autoantibodies in the development of atherosclerosis and age-related immune system decline.
"What is going on?" That was the question with which I began this post. It's the question on the mind of every doctor when a worried patient arrives at the office. Doctors have many tools to help them find the answer to this question. The test for antinuclear antibodies is one of the tools. However, this test is never by itself an answer--it just allows doctors to ask more pointed questions.
I didn't know any of this in 1992 when I learned a laboratory detected antinuclear antibodies in my blood. If my understanding of this test had been better, I might have been more patient as the doctor searched for answers. I might not have been so unsettled by his reticence. How could he tell me what he did not know? He was on the path to discovery and we would both have to wait until information was more definitive.
Lupus is a perplexing disease to diagnose and challenging disease to treat. If the patient understands some of the difficulties, such as what an ANA test can and cannot reveal, then cooperation with the doctor and productive collaboration is more likely to take place.


